Trial Profile
The Pharmacokinetic and Pharmacodynamic Impacts of Depot Medroxyprogesterone Acetate on HIV Pre-exposure Prophylaxis (PrEP)
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Medroxyprogesterone
- Indications HIV infections
- Focus Pharmacokinetics
- Acronyms DynamoPrEP
- 01 Dec 2020 Status changed from active, no longer recruiting to completed.
- 18 Jun 2020 Results published in the JAIDS
- 23 Jan 2020 Status changed from completed to active, no longer recruiting.